Lupin Limited (BOM:500257)
India · Delayed Price · Currency is INR 1,946.30
+94.70 (5.11%)
At close: Aug 7, 2025
Inozyme Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Net Income | - | 32,816 | 19,145 | 4,301 | -15,280 | 12,165 | Upgrade |
Depreciation & Amortization | - | 10,145 | 9,690 | 8,274 | 8,065 | 8,735 | Upgrade |
Other Amortization | - | 339 | 265.2 | 138.9 | 120.3 | 95.8 | Upgrade |
Loss (Gain) From Sale of Assets | - | -2.8 | -11.7 | -209.8 | 29.3 | -9.3 | Upgrade |
Asset Writedown & Restructuring Costs | - | 1,209 | 2,013 | 393.8 | 8,402 | 43.1 | Upgrade |
Loss (Gain) From Sale of Investments | - | -428.2 | -398.4 | -134.8 | -358.4 | -530.7 | Upgrade |
Loss (Gain) on Equity Investments | - | - | - | - | -3.6 | -13.3 | Upgrade |
Stock-Based Compensation | - | 422.5 | 383.3 | 407.6 | 513.9 | 504.3 | Upgrade |
Provision & Write-off of Bad Debts | - | 168.6 | 654.8 | 149.6 | 10.4 | 615 | Upgrade |
Other Operating Activities | - | -564.1 | 3,888 | 2,387 | 2,325 | -1,463 | Upgrade |
Change in Accounts Receivable | - | -7,809 | -2,408 | -1,320 | 2,754 | 8,950 | Upgrade |
Change in Inventory | - | -5,412 | -4,402 | 1,954 | -4,993 | -6,574 | Upgrade |
Change in Accounts Payable | - | 11.2 | 4,188 | 2,168 | 2,342 | -3,735 | Upgrade |
Change in Other Net Operating Assets | - | -894.9 | 3,477 | 462.5 | -252.3 | -566.3 | Upgrade |
Operating Cash Flow | - | 29,999 | 36,484 | 18,972 | 3,673 | 18,218 | Upgrade |
Operating Cash Flow Growth | - | -17.77% | 92.30% | 416.52% | -79.84% | 24.03% | Upgrade |
Capital Expenditures | - | -16,824 | -9,289 | -14,996 | -9,051 | -6,776 | Upgrade |
Sale of Property, Plant & Equipment | - | 293.5 | 122.6 | 385.3 | 70.9 | 62.2 | Upgrade |
Cash Acquisitions | - | -462.6 | -1,465 | -2,910 | -1,468 | - | Upgrade |
Investment in Securities | - | -26,024 | -6,953 | 4,329 | 23,042 | -6,079 | Upgrade |
Other Investing Activities | - | 1,299 | 462.4 | 324.3 | 328.1 | 396.9 | Upgrade |
Investing Cash Flow | - | -41,719 | -17,122 | -12,868 | 12,922 | -12,396 | Upgrade |
Short-Term Debt Issued | - | 12,069 | - | 2,863 | - | 3,531 | Upgrade |
Long-Term Debt Issued | - | 12,209 | - | - | 1,419 | - | Upgrade |
Total Debt Issued | - | 24,277 | - | 2,863 | 1,419 | 3,531 | Upgrade |
Short-Term Debt Repaid | - | - | -15,896 | - | -12,044 | - | Upgrade |
Long-Term Debt Repaid | - | -1,153 | -1,434 | -2,163 | -1,068 | -18,250 | Upgrade |
Total Debt Repaid | - | -1,153 | -17,331 | -2,163 | -13,112 | -18,250 | Upgrade |
Net Debt Issued (Repaid) | - | 23,125 | -17,331 | 699.9 | -11,693 | -14,719 | Upgrade |
Issuance of Common Stock | - | 398.6 | 145.5 | 19.4 | 160.8 | 107.6 | Upgrade |
Common Dividends Paid | - | -3,653 | -1,828 | -1,825 | -2,951 | -2,723 | Upgrade |
Other Financing Activities | - | -2,551 | -2,829 | -2,267 | -1,240 | -1,518 | Upgrade |
Financing Cash Flow | - | 17,319 | -21,842 | -3,373 | -15,723 | -18,853 | Upgrade |
Net Cash Flow | - | 5,599 | -2,481 | 2,732 | 872.2 | -13,031 | Upgrade |
Free Cash Flow | - | 13,175 | 27,195 | 3,976 | -5,378 | 11,441 | Upgrade |
Free Cash Flow Growth | - | -51.55% | 583.93% | - | - | 43.79% | Upgrade |
Free Cash Flow Margin | - | 5.80% | 13.59% | 2.39% | -3.28% | 7.55% | Upgrade |
Free Cash Flow Per Share | - | 28.78 | 59.48 | 8.70 | -11.84 | 25.13 | Upgrade |
Cash Interest Paid | - | 2,551 | 2,829 | 2,267 | 1,240 | 1,518 | Upgrade |
Cash Income Tax Paid | - | 9,060 | 3,261 | 2,432 | -468.8 | 6,954 | Upgrade |
Levered Free Cash Flow | - | -6,136 | 18,774 | 671.65 | 9,344 | 10,122 | Upgrade |
Unlevered Free Cash Flow | - | -4,631 | 20,338 | 2,004 | 9,866 | 10,721 | Upgrade |
Change in Working Capital | - | -14,105 | 855.1 | 3,265 | -150.4 | -1,925 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.